ONO-1110 + Placebo
Phase 2Recruiting 1 views this week 0 watching⚡ Active
Interest: 42/100
42
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hunner Type Interstitial Cystitis
Conditions
Hunner Type Interstitial Cystitis
Trial Timeline
Apr 2, 2025 → Aug 1, 2026
NCT ID
NCT06752603About ONO-1110 + Placebo
ONO-1110 + Placebo is a phase 2 stage product being developed by Ono Pharmaceutical for Hunner Type Interstitial Cystitis. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06752603. Target conditions include Hunner Type Interstitial Cystitis.
Hype Score Breakdown
Clinical
12
Activity
15
Company
15
Novelty
0
Community
0
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06752603 | Phase 2 | Recruiting |
| NCT06752590 | Phase 2 | Recruiting |
| NCT06708416 | Phase 2 | Active |
| NCT06805565 | Phase 2 | Active |
| NCT06792136 | Phase 2 | Active |